Home Cart Quotation About-Us
www.ChineseStandard.net
SEARCH

YY/T 1863-2023 English PDF

Q: How long will the true-PDF of English version of YY/T 1863-2023 be delivered?

Upon your order, we will start to translate YY/T 1863-2023_English as soon as possible, and keep you informed of the progress. The lead time is typically 2 ~ 4 working days. The lengthier the document the longer the lead time.

Q: Can I share the purchased PDF of YY/T 1863-2023_English with my colleagues?

Yes. The purchased PDF of YY/T 1863-2023_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.

Q: Does the price include tax/VAT?

Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries). Avoidance of Double Taxation Agreements (DTAs) between Singapore and 100+ Countries: https://www.iras.gov.sg/taxes/international-tax

Q: Do you accept my currency other than USD?

Yes. If you need your currency to be printed on the invoice, please write an email to Sales@ChineseStandard.net. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.

US$339.00 · In stock
Delivery: <= 4 days. True-PDF full-copy in English will be manually translated and delivered via email.
YY/T 1863-2023: (Biological evaluation of nanomedical devices Release and characterization of nanosilver particles and silver ions from nanosilver-containing dressings)
Status: Valid

Standard ID	USD	BUY PDF	Lead-Days	Standard Title (Description)	Status
YY/T 1863-2023	339	Add to Cart	4 days	(Biological evaluation of nanomedical devices Release and characterization of nanosilver particles and silver ions from nanosilver-containing dressings)	Valid

Basic data

Standard ID: YY/T 1863-2023 (YY/T1863-2023)
Description (Translated English): (Biological evaluation of nanomedical devices Release and characterization of nanosilver particles and silver ions from nanosilver-containing dressings)
Sector / Industry: Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of International Standard: 11.040.30
Word Count Estimation: 16,117
Date of Issue: 2023-01-13
Date of Implementation: 2024-01-15
Issuing agency(ies): State Drug Administration
Summary: This standard specifies the experimental method for evaluating the release of nano-silver particles and silver ions in the release medium from dressings containing nano-silver, as well as the separation, determination and characterization methods of nano-silver particles and silver ions in the release solution. This standard is applicable to the evaluation of the release characteristics of nano-silver particles and silver ions of nano-silver dressings that are in contact with body surface wounds.

YY/T 1863-2023: (Biological evaluation of nanomedical devices Release and characterization of nanosilver particles and silver ions from nanosilver-containing dressings)

---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.040.30 CCSC30 Pharmaceutical Industry Standard of the People's Republic of China Biological evaluation of nanomedical devices in dressings containing nanosilver Release and characterization methods of silver nanoparticles and silver ions Released on 2023-01-13 2024-01-15 Implementation Released by the State Drug Administration

Preface III Introduction IV 1 Scope 1 2 Normative references 1 3 Terms and Definitions 1 4 Abbreviations 1 5 Release experiment of nano-silver particles and silver ions 2 6 Measurement of total silver content and silver ion content in release solution 3 7 Characterization of silver nanoparticles in release solution6 8 Experiment Report 8 Appendix A (informative) Reciprocating support method 9 Appendix B (informative) Experiment of recovery rate of silver ions in simulated body fluid 10 Reference 12

foreword

This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for Standardization Work Part 1.Structure and Drafting Rules for Standardization Documents" drafting. Please note that some contents of this document may refer to patents. The issuing agency of this document assumes no responsibility for identifying patents. This document is proposed by the State Drug Administration. This document is sponsored by the National Medical Device Biological Evaluation Standardization Technical Committee Nano Medical Device Biological Evaluation Sub-Technical Committee (SAC/TC248/SC1) centralized. This document was drafted by. China National Institute for Food and Drug Control, National Center for Nanoscience and Technology. The main drafters of this document. Chen Liang, Liu Lin, Wu Meiyu, Liu Ying, Xu Liming, Xie Liming, Wang Xiaolei, Chen Chunying, Bai Ru.

Introduction

Nanomaterials have unique characteristics such as small size and high specific surface area, and can be used in medicines, medical devices, pharmaceutical packaging materials, as well as food and cosmetics. product additives and other fields. Dressings containing nano-silver have been clinically applied in recent years. This type of product has antibacterial and bactericidal functions, adjustable Control the microbial environment of dressings and wounds, and create favorable conditions for wound healing. However, the potential toxicity risks that nanomaterials may pose require to be evaluated scientifically. The shedding amount of nano-silver particles in the dressing and the size of the shedding particles are used to evaluate the risk of silver particles being absorbed into the body. Important information. The short-term concentrated release of silver ions, the release rate over time and the sustained release period are also used to evaluate the local toxicity and systemic toxicity of silver ions. Important data on toxicity and antimicrobial efficacy. Therefore, the shedding/release characteristics of silver nanoparticles and silver ions, including shedding/release amount, release kinetics, etc. Mechanics is the basis for evaluating the safety and effectiveness of nanosilver-containing dressings. However, there is currently a lack of standardized nanosilver particles in dressings containing nanosilver. Experimental method for grain and silver ion release. According to the publications and literature research in the pharmacopoeias of various countries, the release test methods of drug transdermal patches include shaking table method, flow cell method, paddle-disk method and Reciprocating support method. The release of nano-silver particles and silver ions in dressings containing nano-silver can refer to these methods. However, it is necessary to analyze its In order to evaluate the applicability of the release experiment of silver nanoparticles and silver ions in dressings containing nanosilver, it is necessary to establish the relationship between silver nanoparticles and silver ions in the release solution. Characterization and Measurement Methods. This document presents the experimental methods for evaluating the release of nano-silver particles and silver ions from dressings containing nano-silver in release media, including release methods. method, separation method of nano-silver particles and silver ions, measurement method of total silver content, silver ion content and silver particle content in release liquid, and release method Morphological characterization, chemical composition analysis and number concentration measurement method of silver particles in the tap. Biological evaluation of nanomedical devices in dressings containing nanosilver Release and characterization methods of silver nanoparticles and silver ions

1 Scope

This document specifies the experimental method for evaluating the release of nano-silver particles and silver ions from dressings containing nano-silver in the release medium, as well as the release solution. Separation, determination and characterization methods of medium and nano silver particles and silver ions. This document is applicable to the evaluation of the release characteristics of nano-silver particles and silver ions of nano-silver dressings that are in contact with body surface wounds.

2 Normative references

The contents of the following documents constitute the essential provisions of this document through normative references in the text. Among them, dated references For documents, only the version corresponding to the date is applicable to this document; for undated reference documents, the latest version (including all amendments) is applicable to this document. GB/T 6682 Analytical laboratory water specifications and test methods GB/T 36083 Guidelines for Characterization of Physicochemical Properties Related to Biological Effects of Nanotechnology Silver Nanomaterials GB/T 38261-2019 Nanotechnology measurement of silver content in biological samples Inductively coupled plasma mass spectrometry (PTA) method] ISO /T S19590 Nanotechnology Measurement of Inorganic Nanoparticles in Aqueous Media by Single Particle Inductively Coupled Plasma Mass Spectrometry Pharmacopoeia of the People's Republic of China

3 Terms and Definitions

GB/T 36083, GB/T 38261-2019 and the following terms and definitions apply to this document. 3.1 Woven or non-woven fabric containing nano-silver particles, used for body surface covering and wound protection combination materials, through the nano-silver particles in the dressing Antibacterial and/or bactericidal properties can be used to control the microbial environment of dressings and/or wounds, and create favorable conditions for wound healing. NOTE. Dressings with predominantly metabolic, pharmacological or immunological effects are not included. 3.2 simulated body fluid simulated body fluid; SBF An inorganic solution similar in composition to human blood plasma without organic components.

4 Abbreviations

The following abbreviations apply to this document. ......

Image

Tips & Frequently Asked Questions:

Question 1: How long will the true-PDF of YY/T 1863-2023_English be delivered?

Answer: Upon your order, we will start to translate YY/T 1863-2023_English as soon as possible, and keep you informed of the progress. The lead time is typically 2 ~ 4 working days. The lengthier the document the longer the lead time.

Question 2: Can I share the purchased PDF of YY/T 1863-2023_English with my colleagues?

Answer: Yes. The purchased PDF of YY/T 1863-2023_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.

Question 3: Does the price include tax/VAT?

Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countries

Question 4: Do you accept my currency other than USD?

Answer: Yes. If you need your currency to be printed on the invoice, please write an email to Sales@ChineseStandard.net. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.